Has 1 Biotech Company Found Humira’s Kryptonite?
More times than not, biotechnology and healthcare stocks are the “hot markets” and we’ll explain exactly why. We’ll also take a deep dive into a niche that you must be paying attention to in 2019 if you’re looking to take advantage of the next big trend in health science.
InCaseYouMissedIt: Tiziana Life Sciences (TLSA) Reports Positive Phase 2a Clinical Data
Tiziana Life Sciences plc (TLSA), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, this week announced additional positive Phase 2a clinical data exhibiting impressive clinical activity of Milciclib monotherapy in patients with advanced Sorafenib-resistant or -intolerant patients with unresectable or metastatic hepatocellular carcinoma (HCC).
Here’s Why SNAP Stock Price Continues to Outperform The Broader Market in 2019
There has been bullish sentiment forming, trying to justify Snap stock price following an impressive Q2 earnings report. However, could Snap experience a pullback?